Neil Willner is fast gaining a stellar reputation for representing clients within the cannabis industry, including medical professionals, growers, processors, insurers, distributors and vendors as well as ancillary businesses impacted by the perpetually evolving state and federal regulatory landscape. In addition, Neil defends a full range of medical malpractice cases, centered on complex litigation. He has handled appeals in the New York Appellate Division, First and Second Departments.
Neil is a member of Wilson Elser’s Cannabis Law practice team and leads the firm’s Northeast efforts, helping clients navigate new risk management challenges, business practices and the insurance landscape presented by the rapidly developing area of cannabis and hemp law. Neil works with licensed cannabis operators to comply with obligations under state law and to develop risk management best practices. He advises companies across the supply chain on the quickly evolving hemp-derived cannabidiol (CBD) landscape and the interplay with the U.S. food and drug laws. Neil also works with insurance companies covering cannabis-related risk on developing policy and programs.
Neil is a prolific writer, authoring more than a dozen articles and client alerts about hemp and CBD laws and New York’s cannabis policy. Neil has been quoted by various news outlets including The Guardian, Corporate Counsel, and Business Insurance Magazine for his insights into state and federal issues.
This CLE will explore the current state of New York cannabis regulation, dissect Governor Cuomos recently announced Cannabis Regulation and Taxation Act, and discus how New York fits into the broader legalization sweeping across the country....